Desonide
From Wikipedia, the free encyclopedia
| Systematic (IUPAC) name | |
|---|---|
| (1S,2S,4R,8S,9S,11S,12S,13R)-11-hydroxy-8-(2-hydroxyacetyl)-6,6,9,13-tetramethyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one | |
| Clinical data | |
| Trade names | Desowen |
| AHFS/Drugs.com | monograph |
| MedlinePlus | a605025 |
| Pregnancy cat. | C(US) |
| Legal status | ? |
| Routes | topical |
| Identifiers | |
| CAS number | 638-94-8 |
| ATC code | S01BA11 |
| PubChem | CID 12536 |
| DrugBank | DB01260 |
| ChemSpider | 4470603 |
| UNII | J280872D1O |
| KEGG | D03696 |
| ChEBI | CHEBI:204734 |
| ChEMBL | CHEMBL1201109 |
| Synonyms | (11β,16α)-11,21-Dihydroxy-16,17-[(1-methylethylidene)bis(oxy)]-pregna-1,4-diene-3,20-dione |
| Chemical data | |
| Formula | C24H32O6 |
| Mol. mass | 416.507 |
| SMILES | eMolecules & PubChem |
|
|
| |
|
Desonide is the generic name of a low potency topical corticosteroid that has been available since the 1970s. It is primarily used to treat atopic dermatitis (eczema), seborrheic dermatitis, psoriasis and contact dermatitis in both adults and children. It has a fairly good safety profile[1] and is available as a cream, ointment, lotion, and as a foam under the tradename Verdeso Foam.
[edit] References
- ^ Wong, Vicky Kwan; Brian Fuchs, Mark Lebwohl (2004). "Overview on desonide 0.05%: a clinical safety profile". Journal of Drugs in Dermatology: JDD 3 (4): 393–7. PMID 15303783.
| This dermatologic drug article is a stub. You can help Wikipedia by expanding it. |